Qu Biologics Receives Accelerating Clinical Trial (ACT) Funding for PERIOP-06 Clinical Trial
November 14, 2023 08:00 ET
|
Qu Biologics, Inc.
BURNABY, British Columbia, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform of...
Avid Bioservices Partners With California Institute for Regenerative Medicine (CIRM) to Provide CDMO Services for Cell and Gene Therapy (CGT) Programs
November 08, 2023 08:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Asia-Pacific Anti-inflammatory Therapeutics Market to Reach $40.5 Billion by 2032 With CAGR of 5.4%: Says Allied Market Research
November 05, 2023 18:55 ET
|
Allied Market Research
Wilmington, Delaware, Nov. 05, 2023 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “Asia-Pacific Anti-inflammatory Therapeutics Market, By Drug Class (Biologics, NSAIDs,...
Ulcerative Colitis Market to Grow Positively by 2032, Predicts DelveInsight | Key Companies - Arena, Pfizer, Abivax, InDex, AbbVie, Boehringer Ingelheim, Janssen Pharmaceuticals, Landos Biopharma, NImmune, Merck, Mesoblast
October 24, 2023 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Ulcerative Colitis Market to Grow Positively by 2032, Predicts DelveInsight | Key Companies - Arena, Pfizer, Abivax, InDex, AbbVie, Boehringer...
Avid Bioservices Completes Construction of New, World-Class Cell and Gene Therapy Development and Manufacturing Facility
October 17, 2023 08:05 ET
|
Avid Bioservices, Inc
Avid completes construction of cell and gene theapy facility bringing total revenue generating capacity to up to ~$400 Million annually
Atopic Dermatitis Drugs Market Size to Surpass USD 28.2 billion by 2031, at a CAGR of 8.9% | Transparency Market Research Inc.
October 16, 2023 12:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. -The global atopic dermatitis drugs market is likely to develop at an 8.9% CAGR from 2023 to...
Pharmaceutical Contract Sales Organizations Market Worth $15.82 Billion, Globally, by 2030 - Exclusive Report by The Insight Partners
October 16, 2023 08:31 ET
|
The Insight Partners
Pune, India, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Pharmaceutical companies may outsource their sales and marketing functions to third parties, commonly referred to as contract sales organizations,...
Dyadic Appoints Doug Pace to Its Executive Leadership Team
October 09, 2023 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., Oct. 09, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building...
Avid Bioservices to Participate in RBC Capital Markets Virtual CDMO Conference
September 26, 2023 16:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Regenerative Medicine Market Size is projected to reach USD 72.2 Billion by 2030, growing at a CAGR of 17.6%: Straits Research
September 18, 2023 11:20 ET
|
Straits Research
New York, United States, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Regenerative drugs are used to repair, swap out, and regenerate tissues and organs harmed by injury, disease, or normal aging. Cell...